CDKN2A and head and neck squamous cell carcinoma: In the subgroup of p16/HPV DNA-positive HNSCC (n = 61), a trend towards poorer OS (HR 3.44, 95%-CI 0.85–13.8; p = 0.065) was seen for cases (n = 10) predicted HPV-negative by the 24-miRNA signature compared to HPV-positive predicted cases (n = 51; Figure S3A).